Case Fatality Risk Among Individuals Vaccinated with rVSVΔG-ZEBOV-GP A Retrospective Cohort Analysis of Patients with Confirmed Ebola Virus Disease i

Coulborn, R., Bastard, M., Peyraud, N., et al. (2024). Case Fatality Risk Among Individuals Vaccinated with rVSVΔG-ZEBOV-GP: A Retrospective Cohort Analysis of Patients with Confirmed Ebola Virus Disease in the Democratic Republic of the Congo. (Abstract only; full article free with registration.) The Lancet Infectious Diseases. 24(6):602-610.
The authors a conducted a retrospective cohort study to determine the protective effect against death of the rVSVĪ”G-ZEBOV-GP vaccine. The found the vaccine was protective for all confirmed cases admitted to an Ebola health facility, including when adjusted for treatment, age group, and time from symptom onset to admission.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.